Staphylococcus aureus infections in children with congenital heart disease

Journal of the Pediatric Infectious Diseases Society

Volumn 2, Issue 4, 2013, Pages 337-344

  McNeil, J Chase ^a   Ligon, John A ^a   Hulten, Kristina G ^a   Dreyer, W Jeffrey ^a   Heinle, Jeffrey S ^a   Mason, Edward O ^a   Kaplan, Sheldon L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHLORHEXIDINE GLUCONATE;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; AORTA COARCTATION; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; CARDIOVASCULAR RISK; CHILD; CONGENITAL HEART DISEASE; CYANOTIC HEART DISEASE; DISEASE SURVEILLANCE; FEMALE; HEART INJURY; HEART SEPTUM DEFECT; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 84899114553     PISSN: 20487193     EISSN: 20487207     Source Type: Journal    
DOI: 10.1093/jpids/pit037     Document Type: Article

References (40)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39:1890-900.
2. Rosenthal LB, Feja KN, Levasseur SM, et al. The changing epidemiology of pediatric endocarditis at a children's hospital over seven decades. Pediatr Cardiol 2010; 31:813-20.
3. Wisplinghoff H, Seifert H, Tallent SM, et al. Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 2003; 22:686-91.
4. Coward K, Tucker N, Darville T. Infective endocarditis in Arkansan children from 1990 through 2002. Pediatr Infect Dis J 2003; 22:1048-52.
5. Selton-Suty C, Celard M, Le Moing V, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 2012; 54:1230-9.
6. Day MD, Gauvreau K, Shulman S, Newburger JW. Characteristics of children hospitalized with infective endocarditis. Circulation 2009; 119:865-70.
7. Allpress AL, Rosenthal GL, Goodrich KM, et al. Risk factors for surgical site infections after pediatric cardiovascular surgery. Pediatr Infect Dis J 2004; 23:231-4.
8. Ben-Ami E, Levy I, Katz J, et al. Risk factors for sternal wound infection in children undergoing cardiac surgery: a case-control study. J Hosp Infect 2008; 70:335-40.
9. Chang FY, MacDonald BB, Peacock JE Jr, et al. A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance. Medicine (Baltimore) 2003; 82:322-32.
10. Kaasch AJ, Fowler VG Jr, Rieg S, et al. Use of a simple criteria set for guiding echocardiography in nosocomial Staphylococcus aureus bacteremia. Clin Infect Dis 2011; 53:1-9.
11. Carillo-Marquez MA, Hulten KG, Hammerman W, et al. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009; 28:1076-80.
12. Carrillo-Marquez MA, Hulten KG, Mason EO, Kaplan SL. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J 2010; 29:410-4.
13. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-78; quiz 279-80.
14. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011; 52:e162-93.
15. Bleasdale SC, Trick WE, Gonzalez IM, et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007; 167:2073-9.
16. DeRiso AJ 2nd, Ladowski JS, Dillon TA, et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996; 109: 1556-61.
17. McNeil JC, Hulten KG, Kaplan SL, et al. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J 2013; 32: 124-8.
18. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Inf Dis 2005; 40:1785-91.
19. Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J 2006; 25:349-53.
20. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 30:633-8.
21. Bendig EA, Singh J, Butler TJ, Arrieta AC. The impact of the central venous catheter on the diagnosis of infectious endocarditis using Duke criteria in children with Staphylococcus aureus bacteremia. Pediatr Infect Dis J 2008; 27:636-9.
22. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36:309-32.
23. Institute CaLS. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20-U.Wayne, PA: CLSI, 2010.
24. Noguchi N, Hase M, Kitta M, et al. Antiseptic susceptibility and distribution of antiseptic-resistance genes in methicillin-resistant Staphylococcus aureus. FEMSMicrobiol Lett 1999; 172:247-53.
25. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of communityacquired methicillin-resistant Staphylococcus aureus. Pediatrics 2005; 115:642-8.
26. Abraham J, Mansour C, Veledar E, et al. Staphylococcus aureus bacteremia and endocarditis: the Grady Memorial Hospital experience with methicillin-sensitive S aureus and methicillinresistant S aureus bacteremia. Am Heart J 2004; 147:536-9.
27. Valente AM, Jain R, Scheurer M, et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 2005; 115:e15-9.
28. Suryati BA, Watson M. Staphylococcus aureus bacteraemia in children: a 5-year retrospective review. J Paediatr Child Health 2002; 38:290-4.
29. Ong J, Brizard CP, d'Udekem Y, et al. Repair of atrioventricular septal defect associated with tetralogy of Fallot or double-outlet right ventricle: 30 years of experience. Ann Thorac Surg 2012; 94:172-8.
30. Fisher RD, Bone DK, Rowe RD, Gott VL. Complete atrioventricular canal associated with tetralogy of Fallot: clinical experience and operative methods. J Thorac Cardiovasc Surg 1975; 70:265-71.
31. Hoohenkerk GJ, Schoof PH, Bruggemans EF, et al. 28 years' experience with transatrial-transpulmonary repair of atrioventricular septal defect with tetralogy of Fallot. Ann Thorac Surg 2008; 85:1686-9.
32. Saiman L, Prince A, Gersony WM. Pediatric infective endocarditis in the modern era. J Pediatr 1993; 122:847-53.
33. Humpl T, McCrindle BW, Smallhorn JF. The relative roles of transthoracic compared with transesophageal echocardiography in children with suspected infective endocarditis. J Am Coll Cardiol 2003; 41:2068-71.
34. Verhagen DW, Hermanides J, Korevaar JC, et al. Prognostic value of serial C-reactive protein measurements in left-sided native valve endocarditis. Arch Intern Med 2008; 168: 302-7.
35. Hogevik H, Olaison L, Andersson R, Alestig K. C-reactive protein is more sensitive than erythrocyte sedimentation rate for diagnosis of infective endocarditis. Infection 1997; 25:82-5.
36. Penk JS, Webb CL, Shulman ST, Anderson EJ. Echocardiography in pediatric infective endocarditis. Pediatr Infect Dis J 2011; 30:1109-11.
37. Anand IS, Latini R, Florea VG, et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation 2005; 112:1428-34.
38. Haber HL, Leavy JA, Kessler PD, et al. The erythrocyte sedimentation rate in congestive heart failure. N Engl J Med 1991; 324: 353-8.
39. McGann P, Kwak YI, Summers A, et al. Detection of qacA/B in clinical isolates of methicillin-resistant Staphylococcus aureus from a regional healthcare network in the eastern United States. Infect Control Hosp Epidemiol 2011; 32:1116-9.
40. Fritz SA, Hogan PG, Camins BC, et al. Mupirocin and chlorhexidine resistance in Staphylococcus aureus in patients with community-onset skin and soft tissue infections. Antimicrob Agents Chemother 2013; 57:559-68.